[go: up one dir, main page]

ES2059677T3 - 1,2,3,4-tetrahidro-1,9-acridindiaminas, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

1,2,3,4-tetrahidro-1,9-acridindiaminas, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
ES2059677T3
ES2059677T3 ES89120463T ES89120463T ES2059677T3 ES 2059677 T3 ES2059677 T3 ES 2059677T3 ES 89120463 T ES89120463 T ES 89120463T ES 89120463 T ES89120463 T ES 89120463T ES 2059677 T3 ES2059677 T3 ES 2059677T3
Authority
ES
Spain
Prior art keywords
rent
medicines
acridindiaminas
tetrahidro
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89120463T
Other languages
English (en)
Inventor
Gregory Michael Shutske
Kevin James Kapples
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2059677T3 publication Critical patent/ES2059677T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)

Abstract

SE DESCUBREN COMPUESTOS TENIENDO LA FORMULA DONDE N ES 1,2 O 3; X ES HIDROGENO, ALQUILO INFERIOR, HALOGENO, HIDROXILO, NITROGENO O TRIFLUOROMETILO; R1 Y R2 SON CADA UNO INDEPENDIENTEMENTE HIDROGENO, ALQUILO INFERIOR O ARILO ALQUILO INFERIOR, PERO AMBOS NO PUEDEN SER ARILO ALQUILO INFERIOR SIMULTANEAMENTE; R3 Y R4 SON INDEPENDIENTEMENTE HIDROGENO, ALQUILO INFERIOR, ARILO ALQUILO INFERIOR, FORMILO O ALQUILO INFERIOR CARBONILO, O ALTERNATIVAMENTE EL GRUPO -NR3R4 TOMADO EN SU TOTALIDAD CONSTITUYE ESTEREO ISOMEROS DE ELLOS Y SALES DE ADICCION ACIDA FARMACEUTICAMENTE ACEPTABLES DE ELLOS Y UN PROCESO PARA SU PREPARACION. LOS COMPUESTOS SE USAN PARA EL TRATAMIENTO DE VARIAS DISFUNCIONES DE MEMORIA CARACTERIZADAS POR REDUCCION DE LA FUNCION DEL COMPLEJO DE LA VITAMINA B, TALES COMO EL MAL DE ALZHEIMER, Y ADEMAS PUEDE, SER USADA COMO MEDICAMENTOS.
ES89120463T 1988-11-09 1989-11-06 1,2,3,4-tetrahidro-1,9-acridindiaminas, un procedimiento para su preparacion y su uso como medicamentos. Expired - Lifetime ES2059677T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/269,038 US4868177A (en) 1988-11-09 1988-11-09 1,2,3,4-tetrahydro-1,9-acridinediamines, pharmaceutical compositions and use

Publications (1)

Publication Number Publication Date
ES2059677T3 true ES2059677T3 (es) 1994-11-16

Family

ID=23025549

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89120463T Expired - Lifetime ES2059677T3 (es) 1988-11-09 1989-11-06 1,2,3,4-tetrahidro-1,9-acridindiaminas, un procedimiento para su preparacion y su uso como medicamentos.

Country Status (18)

Country Link
US (1) US4868177A (es)
EP (1) EP0368188B1 (es)
JP (1) JPH03153667A (es)
KR (1) KR900007808A (es)
AT (1) ATE111899T1 (es)
AU (1) AU623701B2 (es)
CA (1) CA2002531A1 (es)
DE (1) DE68918402T2 (es)
DK (1) DK166620B1 (es)
ES (1) ES2059677T3 (es)
FI (1) FI895288A7 (es)
HU (1) HU208530B (es)
IE (1) IE64499B1 (es)
IL (1) IL92233A0 (es)
NO (1) NO894445L (es)
NZ (1) NZ231293A (es)
PT (1) PT92234B (es)
ZA (1) ZA898498B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282959A3 (en) * 1987-03-17 1989-05-31 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 9-amino-tetrahydro-acridines and related compounds, a process for their preparation and their use as medicaments
US6075144A (en) * 1987-04-20 2000-06-13 Hoechst Marion Roussel, Inc. 9-hydroxyamino tetrahydroacridine and related compounds
US4970316A (en) * 1987-05-07 1990-11-13 American Home Products Corporation Pyrano-, thiopyrano- and cyclohexylquinolines as inhibitors of interleukin 1
US5053513A (en) * 1990-03-29 1991-10-01 Hoechst-Roussel Pharmaceuticals Incorporated Method of reducing a carbonyl containing acridine
US5783584A (en) * 1995-12-11 1998-07-21 Mayo Foundation For Medical Education And Research THA analogs useful as cholinesterase inhibitors
US5929093A (en) * 1996-06-13 1999-07-27 Mayo Foundation For Medical Education And Research Bifunctional acetylcholinesterase reactivators
NZ510685A (en) 1998-09-30 2003-10-31 Takeda Chemical Industries Ltd Drugs for improving vesical excretory strength
UY28538A1 (es) * 2003-09-26 2005-04-29 Vertex Pharma Derivados de fenil-piperazina como moduladores de receptores muscarínicos
WO2005072713A2 (en) 2004-01-27 2005-08-11 The Feinstein Institute For Medical Research Cholinesterase inhibitors for treating inflammation
DE102021119724A1 (de) * 2021-07-29 2023-02-02 Brückner Maschinenbau GmbH & Co. KG Folienaufwickelsystem, Verbund aus einer Folienreckanlage und einem solchen Folienaufwickelsystem und Verwendung eines solchen Verbunds zur Herstellung von Dünnstfilmen und Membranen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
EP0268871A1 (en) * 1986-10-31 1988-06-01 Sumitomo Pharmaceuticals Company, Limited Quinoline derivatives
EP0282959A3 (en) * 1987-03-17 1989-05-31 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 9-amino-tetrahydro-acridines and related compounds, a process for their preparation and their use as medicaments
US5013741A (en) * 1987-09-08 1991-05-07 Hoechst-Roussel Pharmaceuticals Incorporated N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives

Also Published As

Publication number Publication date
NZ231293A (en) 1991-09-25
DK557189D0 (da) 1989-11-08
FI895288A0 (fi) 1989-11-07
DK557189A (da) 1990-05-30
HU208530B (en) 1993-11-29
DK166620B1 (da) 1993-06-21
CA2002531A1 (en) 1990-05-09
KR900007808A (ko) 1990-06-02
IE893592L (en) 1990-05-09
NO894445D0 (no) 1989-11-08
JPH03153667A (ja) 1991-07-01
PT92234B (pt) 1995-07-06
ZA898498B (en) 1990-08-29
EP0368188B1 (en) 1994-09-21
DE68918402T2 (de) 1995-03-09
HU895830D0 (en) 1990-01-28
ATE111899T1 (de) 1994-10-15
AU4442389A (en) 1990-05-17
FI895288A7 (fi) 1990-05-10
IE64499B1 (en) 1995-08-09
DE68918402D1 (de) 1994-10-27
AU623701B2 (en) 1992-05-21
US4868177A (en) 1989-09-19
NO894445L (no) 1990-05-10
PT92234A (pt) 1990-05-31
IL92233A0 (en) 1990-07-26
EP0368188A1 (en) 1990-05-16

Similar Documents

Publication Publication Date Title
ES2104572T3 (es) N-aminocarbamatos afines a la fisostigmina, un procedimiento para su preparacion y su uso como medicamentos.
DE3888441D1 (de) Benzoxazin-Verbindungen und ihre pharmazeutische Anwendung.
NO931635D0 (no) Fremgangsmaate for fremstilling av kinazolin-derivater
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
SE9702564D0 (sv) New compounds
ATE226247T1 (de) Menschliche neuronale nikotin-acetylcholin- rezeptor-verbindungen und methoden ihres einsatzes
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
NO20000313D0 (no) Nye forbindelser
ES2059677T3 (es) 1,2,3,4-tetrahidro-1,9-acridindiaminas, un procedimiento para su preparacion y su uso como medicamentos.
NO179612C (no) Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser
DE3769683D1 (de) Farblose ketimine, ihre herstellung und ihre verwendung als vernetzungsmittel.
TR200001141T2 (tr) Motilin reseptörü antagonistleri olarak yararlı siklopenten türevleri.
ES2037670T3 (es) Procedimiento para la preparacion de complejos de (2,2-bis(aminometil)-1,3-propanodiol-n,n') platino.
ES2081636T3 (es) Preparacion de piperidinas sustituidas.
ATE157002T1 (de) Entzündungshemmende mittel
SE8505887L (sv) Indoler
TR199901381A2 (xx) Diaza-spiro$3,5]nonan t�revleri.
ES2038127T3 (es) Procedimiento para preparar monosulfactamas.
SE9702563D0 (sv) Compounds
ES2052598T3 (es) Derivados de hetaril-oxi-beta-carbolinas, su preparacion y utilizacion como medicamentos.
TR199802042T2 (xx) Yeni karbon asidi t�revleri, �retimleri ve kullan�mlar�.
AR005619A1 (es) Procedimiento para preparar compuestos dicetonicos
ES2054186T3 (es) Composicion antihepatopatica.
TR199801949T2 (xx) Ast�m� tedavi edici ve ba����kl�k bast�r�c� maddeler olarak yeni spesifik imm�nofilin ligandlar.
NO870398D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive organiskeplatinakomplekser.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 368188

Country of ref document: ES